Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-08-004952
Filing Date
2008-07-15
Accepted
2008-07-15 14:55:17
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL BIOTECH FUND II, L.P.RA CAPITAL BIOTECH FUND, L.P.RICHARD H. ALDRICH

Document Format Files

Seq Description Document Type Size
1 RA CAPITAL MANAGEMENT, LLC b71086rasc13g.htm SC 13G 81133
  Complete submission text file 0000950135-08-004952.txt   83130
Mailing Address 19 PRESIDENTIAL WAY WOBURN MA 01801
Business Address 19 PRESIDENTIAL WAY WOBURN MA 01801 781-994-0300
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

EIN.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48819 | Film No.: 08952667
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199
Business Address 111 HUNTINGTON AVE, SUITE 610 BOSTON MA 02199 617-778-2512
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G